Mitral insufficiency and morbidity and mortality in left ventricular dysfunction

Canadian Journal of Cardiology

Volumn 23, Issue 10, 2007, Pages 797-800

  Baskett, Roger J F ^a,c   Exner, Derek V ^b   Hirsch, Gregory M ^a   Ghali, William A ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c NONE   (Canada)

Author keywords

Congestive heart failure; Left ventricular dysfunction; Mitral insufficiency

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; ENALAPRIL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; PROGNOSIS; RISK ASSESSMENT;

EID: 34748860438     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(07)70830-9     Document Type: Article

References (24)

1. McMurray J, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000;83:596-602.
2. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993;22:6A-13A.
3. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
4. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997;336:525-33.
5. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000;102:1126-31.
6. Steptoe A, Mohabir A, Mahon N, McKenna WJ. Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy. Heart 2000;83:645-50.
7. Junker A, Thayssen P, Nielsen B, Andersen P. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology 1993;83:14-20.
8. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-64.
9. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002;144:524-9.
10. Trichon BH, Felker GM, Shaw LK, Cabell CH, O'Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003;91:538-43.
11. Cabell CH, Trichon BH, Velazquez EJ, et al. Importance of echocardiography in patients with severe nonischemic heart failure: The second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study. Am Heart J 2004;147:151-7.
12. Robbins JD, Maniar PB, Cotts W, Parker MA, Bonow RO, Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003;91:360-2.
13. Smolens I, Pagani F, Bolling S. Mitral vane repair in heart failure. Eur J Heart Fail 2000;2:365-71.
14. Studies of left ventricular dysfunction (SOLVD) - rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 1990;66:315-22. (Erratum in 1990;66:1026).
15. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302.
16. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91. (Erratum in 1992;327:1768).
17. Greenberg B, Quinones M, Koilpillai C, et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 1995;91:2573-81.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-220.
20. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35.
21. Rector TS, Johnson G, Dunkman WB, et al. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(6 Suppl):VI71-7.
22. Bishay E, McCarthy P, Cosgrove D, et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 2000;17:213-21.
23. Chen F, Adams D, Aranki S, et al. Mitral valve repair in cardiomyopathy. Circulation 1998;98(19 Suppl):II124-7.
24. Calafiore A, Gallina S, DiMauro M, et al. Mitral valve procedure in dilated cardiomyopathy: Repair or replacement? Ann Thorac Surg 2001;71:1146-52.